CG Oncology (CGON) Total Current Liabilities (2023 - 2026)
CG Oncology posted quarterly Total Current Liabilities of $35.2 million for Q1 2026, up 55.53% year-on-year from $22.6 million in Q1 2025, and up 14.2% on a QoQ basis from $30.8 million in Q4 2025.
CG Oncology (CGON) has 4 years of Total Current Liabilities data on file, last reported at $35.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 55.53% year-over-year to $35.2 million; the trailing twelve-month figure through Mar 2026 stood at $35.2 million (up 55.53% YoY), and the FY2025 full-year result was $30.8 million, up 44.31% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $35.2 million, up from $30.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $35.2 million in Q1 2026 and bottomed at $10.0 million in Q1 2024.
- The 4-year median for Total Current Liabilities is $22.0 million (2024), against an average of $22.3 million.
- Peak annual rise in Total Current Liabilities reached 156.31% in 2025, while the deepest fall reached 44.31% in 2025.
- A 4-year view of Total Current Liabilities shows it stood at $14.3 million in 2023, then jumped by 49.91% to $21.4 million in 2024, then soared by 44.31% to $30.8 million in 2025, then increased by 14.2% to $35.2 million in 2026.
- The last three Total Current Liabilities figures came in at $35.2 million (Q1 2026), $30.8 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 35.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.22 Mn |
| Dec 31, 2025 | 30.84 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 30.38 Mn |
| Mar 31, 2025 | 22.64 Mn |
| Dec 31, 2024 | 21.37 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Jun 30, 2024 | 11.85 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 14.25 Mn |